A new study commissioned by AbbVie and prepared by HTANALYSTS has found that people on the ‘front line’ of caring for someone with advanced Parkinson’s disease secure the most significant gains when patients living with the condition can access standard-of-care treatments. …
Australian study finds families gain the most with treatment of advanced Parkinson’s disease
March 20, 2024 Latest NewsBioPharma
Latest Video
New Stories
-
Australian company partners to take innovative therapy to Asia
June 17, 2026 - - Latest News -
Novartis names interim leader for Australia and NZ after Country President departs
June 17, 2026 - - Latest News -
These outcomes are mostly about the choices Australia is making
June 17, 2026 - - Latest News -
AstraZeneca confirms pricing the issue, and acts to create a patient access program
June 16, 2026 - - Latest News -
When good policy becomes self defeating, Australia must at least have a discussion about the obvious solution
June 16, 2026 - - Latest News -
Entropy Neurodynamics clears safety hurdle for IV psilocin trial in binge eating disorder
June 15, 2026 - - Australian Biotech -
Paradigm reaches global milestone as Phase 3 osteoarthritis trial completes enrolment
June 15, 2026 - - Australian Biotech